No idk why my link was different. I double checked

No idk why my link was different. I double checked.

“Record Verification: May 2021
Overall Status: Recruiting
Study Start: September 9, 2021
Primary Completion: January 2022 [Anticipated]
Study Completion: February 2022 [Anticipated]
First Submitted: May 24, 2021
First Submitted that
Met QC Criteria: May 24, 2021
First Posted: May 25, 2021 [Actual]
Last Update Submitted that
Met QC Criteria: September 14, 2021
Last Update Posted: September 16, 2021 [Actual]”




Last updated September 2021. So Disregard.

Why are people saying the Brazil trial is on. I can’t find anything.

Daniel Rizzo
Founder & CEO | FireGate Biotech™
AI Platform: Lux Veritas™

Federal Whistleblower Case References
• HHS & SEC Whistleblower ID – HL-1412396
• DOJ Investigation Report / Whistleblower ID – 20250705-0001
• NIH Case Reference – CS1137565 ( IC IG / 50 U.S.C. § 3033 )

Website: FireGateBiotech.com
Headquarters: Washington, DC
Mailing & correspondence: 1930 18th St NW Suite B2 PMB 2161, Washington DC 20009

(For official updates and correspondence — I will no longer be posting here or responding via DMs)

Contact FireGate Biotech

Principal Investigator:
FG001|FG002|FG003
https://firegatebiotech.com/2025

FG-001: Integrated Triplet Immunotherapy for Functional HIV Cure
FG-002: Triplet Immunologic Modulation in Oncology — NF-κB / IL-1Ra Axis
FG-003: Neuro-Immune Repair Triplet — Concept and Combination Framework
CCR5 Antagonists & Triplet Immunotherapy Synergy in HIV
HIV Cure Pathways — Functional-Cure Framework Overview
FG-003 Neuro-Immune Repair Triplet — IP & Combination Strategy


— Jeremiah 51:36